While trends in life expectancy and premature mortality rates have indicated progress in the clinical treatment of cardiovascular diseases (CVD) – and most notably in high-income countries – CVD remains the leading cause of death worldwide, as well as the leading cause of premature death, per data from the Global Burden of Disease study. Throughout the past several decades, the primary focus of public health efforts has been on decreasing mortality rates associated with major cardiovascular diseases, such as ischaemic heart disease and stroke. In lower-income countries, elevated CVD risk remains due to unchanging risk factors, including high tobacco consumption, poor blood pressure, lipid, and glucose control, as well as an ever-increasing adoption of the Western diet.
New research reveals that current statistics greatly underestimate the number of people suffering from inflammatory bowel diseases (IBD). While the CDC estimates approximately 1 to 1.3 million Americans suffer from IBD, the number of people affected by the condition could be as much as three times higher than previously believed.